Summary
The study was aimed at testing the hypothesis that sulfonylureas do not readily penetrate the pancreaticβ-cells but more probably stimulate insulin release by a direct action on theβ-cell plasma membrane. Uptake of radioactively labelled tolbutamide and glibenclamide by microdissected pancreatic islets of obesehyperglycemic mice was compared with the uptake of 3-O-methyl-D-glucose, to which theβ-cells are permeable. In contrast to tolbutamide, glibenclamide was taken up in amounts exceeding the 3-O-methyl-D-glucose space of islets incubated in the absence of serum albumin. Uptake of the sulfonylureas was easily reversible. It was depressed by serum albumin, whereas glucose, leucine or diazoxide had no effects. Antimycin A,p-chloromercuriphenylsulfonic acid and chlorpromazine, all of which increase the uptake of extracellular space markers, strongly stimulated the islet uptake of tolbutamide and glibenclamide but had no effect on the uptake of glibenclamide by subcellular particles of homogenized islets. The results suggest that sulfonylureas bind reversibly to islet tissue but are normally restricted to the outside of theβ-cells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ashcroft, S.J.H., Hedeskov, C.J., Randle, P.J.: Glucose metabolism in mouse pancreatic islets. Biochem. J.118, 143–154 (1970).
Ashcroft, S.J.H., Randle, P.J., Täljedal, I.-B.: Cyclic nucleotide phosphodiesterase activity in normal mouse pancreatic islets. FEBS Letters20, 263–266 (1972).
Bänder, A., Pfaff, W., Schmidt, F.H., Stork, H., Schrö-der, H.G.: Zur Pharmakologie von HB 419, einem neuen, stark wirksamen oralen Antidiabeticum. Arzneimittel-Forsch.19, 1363–1368 (1969).
Bänder, A., Scholz, J.: Spezielle pharmakologische Untersuchungen mit D 860. Dtsch. med. Wschr.81, 889–891 (1956).
Bloom, G.D., Hellman, B., Idahl, L.-Å., Lernmark, Å., Sehlin, J., Täljedal, I.-B.: Effects of organic mercurials on mammalian pancreaticβ-cells: insulin release, glucose transport, glucose oxidation, membrane permeability, and ultrastructure. Biochem. J.129, 241–254 (1972).
Grodsky, G.M.: Discussion at the second Capri conference. Acta diabet. lat.5 (suppl. 1), 256–259 (1968).
Grodsky, G.M.: Insulin and the pancreas. Vitam. and Horm.28, 37–101 (1970).
Hellerström, C.: A method for the microdissection of intact pancreatic islets of mammals. Acta endocr. (Kbh.)45, 122–132 (1964).
Hellman, B.: Methodological approaches to studies on the pancreatic islets. Diabetologia6, 110–120 (1970).
Hellman, B., Idahl, L.-Å., Danielsson, Å.: Adenosine triphosphate levels of mammalian pancreaticβ-cells after stimulation with glucose and hypoglycemic sulfonylureas. Diabetes18, 509–516 (1969).
Hellman, B., Idahl, L.-Å., Tjälve, H., Danielsson, Å., Lernmark, Å.: Beobachtungen zum Wirkungsmechanismus des hypoglykämisch wirksamen Sulfonylharnstoff-Präparates HB 419. Arzneimittel-Forsch.19, 1472–1476 (1969).
Hellman, B., Sehlin, J., Täljedal, I.-B.: The pancreaticβ-cell recognition of insulin secretagogues: II. Site of action of tolbutamide. Biochem. Biophys. Res. Comm.45, 1384–1388 (1971a).
Hellman, B., Sehlin, J., Täljedal, I.-B.: Transport ofα-aminoisobutyric acid in mammalian pancreaticβ- cells. Diabetologia7, 256–265 (1971b).
Hellman, B., Sehlin, J., Täljedal, I.-B.: Effects of glucose and other modifiers of insulin release on the oxidative metabolism of amino acids in micro-dissected pancreatic islets. Biochem. J.123, 513–521 (1971c).
Heptner, W., Kellner, H.-M., Christ, O., Weirauch, D.: Metabolismus von HB 419 am Tier. Arzneimittel-Forsch.19, 1400–1404 (1969).
Hogben, C.A.M.: Biological membranes and their passage by drugs. In: Concepts in Biochemical Pharmacology, ed. by B.B. Brodie and J.R. Gillette, pp. 1–8. Berlin, Heidelberg, New York: Springer 1971.
Howell, S.L., Lacy, P.E.: Studies on the effect of HB 419 (glibenclamide) on isolated islets and granules. Horm. Metab. Res.1, 45–47, (1969).
Judis, J.: Binding of sulfonylureas to serum proteins. J. Pharm. Sci.61, 89–93 (1972).
Kaniuga, Z., Bryla, J., Slater, E.C.: Inhibitors around the antimycin-sensitive site in the respiratory chain. In: Inhibitors. Tools in Cell Research, ed. by T. Bücher and H. Sies, pp. 282–300. Berlin, Heidelberg, New York: Springer 1969.
Lernmark, Å.: Isolated mouse islets as a model for studying insulin release. Acta diabet. lat.8, 649–679 (1971).
Löffler, G., Trautschold, I., Schweiter, T., Lohmann, E.: Zur Wirkung von HB 419 und Tolbutamid in isolierten Langerhans'schen Inseln der Ratte. Arzneimittel-Forsch.19, 1469–1472 (1969).
Loubatieres, A.: Stimulators and inhibitors of insulin secretion, physiological and pharmacological interferences, synergisms and antagonisms. Acta diabet. lat.5 (suppl. 1), 220–252 (1968).
Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J.: Protein measurement with the Folin phenol reagent. J. biol. Chem.193, 265–275, (1951).
Montague, W., Taylor, K.W.: Islet-cell metabolism during insulin release. Effects of glucose, citrate, octanoate, tolbutamide, glucagon and theophylline. Biochem. J.115, 257–262 (1969).
Orci, L., Ammon, H.P.T., Steinke, J.: The effect of chlorpromazine (CPZ) on insulin release from isolated pancreatic rat islets: a correlated morphological and biochemical study. Diabetologia8, 61 (1972).
Stork, H., Schmidt, F.H., Westman, S., Hellerström, C.: Action of some hypoglycaemic sulfonylureas on the oxygen consumption of isolated pancreatic islets of mice. Diabetologia5, 279–283 (1969).
Stowers, J.M., Mahler, R.F., Hunter, R.B.: Pharmacology and the mode of action of the sulphonylureas in man. Lancet1958 I, 278–283.
Wick, A.N., Britton, B., Grabowski, R.: The action of a sulfonylurea hypoglycemic agent (orinase) in extrahepatic tissues. Metabolism5, 739–743 (1956).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hellman, B., Sehlin, J. & Täljedal, I.B. The pancreatic β-cell recognition of insulin secretagogues. Diabetologia 9, 210–216 (1973). https://doi.org/10.1007/BF01219785
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01219785